INO therapy services
Ended Awarded Last action
- Contract number
- HT940623F0133
- Awardee
-
INO Therapeutics LLC UEI XXQHL619FUN6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $379,698
Award facts
- Opportunity
-
- NOI - Inhaled Nitric Oxide (INO) Therapy Services - Sole Source Special Notice · HT940623R0015 · Posted Aug 2, 2023
- Contract value 76% obligated
-
- $482,284.00 Current, with exercised options
- $499,268.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, VA 23708, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $85,602 | |
| Exercise an Option | $88,924 | |
| Funding Only Action | $102,586 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $16,984 | |
| Funding Only Action | $85,602 | |
| Original award | $0 |
About this award
The Defense Health Agency issued a delivery order to INO Therapeutics LLC on October 1, 2023, for inhaled nitric oxide therapeutic gases and respiratory therapy services, with a ceiling value of $512,930 and an ultimate completion date of September 30, 2027.
The order is placed against the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Place of performance is Portsmouth, VA 23708. INO Therapeutics is a foreign-owned subsidiary of Medtronic Inc. that supplies inhaled nitric oxide therapeutic gases, INOMAX delivery systems, and respiratory therapy services to federal healthcare agencies as a prime contractor. The vendor operates exclusively as a prime with no subcontractor footprint and carries no set-aside designations. Service Contract Inventory reporting shows minimal SCI-reportable service revenue on this vendor's portfolio; the federal business is predominantly goods procurement rather than services.
Quick answers
Who was awarded contract HT940623F0133?
HT940623F0133 was awarded to INO Therapeutics LLC by Defense Health Agency (Department of Defense) on October 1, 2023.
How much is contract HT940623F0133 worth?
The government has obligated $379,698 on HT940623F0133. Its current value, with exercised options, is $482,284. Its potential value, with all options, is $499,268.
Is contract HT940623F0133 an order under another contract?
Yes. HT940623F0133 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HT940623F0133 competed?
The extent of competition for HT940623F0133 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award